- Previous Close
422.54 - Open
422.54 - Bid 415.20 x 100
- Ask 416.65 x 100
- Day's Range
415.21 - 423.81 - 52 Week Range
398.50 - 548.88 - Volume
470,168 - Avg. Volume
721,249 - Market Cap (intraday)
33.822B - Beta (5Y Monthly) 1.39
- PE Ratio (TTM)
38.90 - EPS (TTM)
10.69 - Earnings Date May 1, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
498.01
IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.
www.idexx.com11,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: IDXX
View MorePerformance Overview: IDXX
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IDXX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IDXX
View MoreValuation Measures
Market Cap
33.82B
Enterprise Value
34.52B
Trailing P/E
38.98
Forward P/E
35.09
PEG Ratio (5yr expected)
3.54
Price/Sales (ttm)
8.88
Price/Book (mrq)
21.20
Enterprise Value/Revenue
8.86
Enterprise Value/EBITDA
27.16
Financial Highlights
Profitability and Income Statement
Profit Margin
22.78%
Return on Assets (ttm)
22.69%
Return on Equity (ttm)
57.66%
Revenue (ttm)
3.9B
Net Income Avi to Common (ttm)
887.87M
Diluted EPS (ttm)
10.69
Balance Sheet and Cash Flow
Total Cash (mrq)
288.27M
Total Debt/Equity (mrq)
61.87%
Levered Free Cash Flow (ttm)
734.99M